ZAI LAB LTD0000006 (1ZLB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.018x

Based on the latest financial reports, ZAI LAB LTD0000006 (1ZLB) has a cash flow conversion efficiency ratio of -0.018x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-11.91 Million ≈ $-13.93 Million USD) by net assets (€661.98 Million ≈ $773.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 1ZLB equity to assets ratio to measure how much of total assets are equity-financed.

ZAI LAB LTD0000006 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how ZAI LAB LTD0000006's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore ZAI LAB LTD0000006 long-term investment allocation to see how much of total assets are deployed in long-term investments.

ZAI LAB LTD0000006 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ZAI LAB LTD0000006 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Monadelphous Group Ltd
F:8MP
0.043x
Austevoll Seafood ASA
OL:AUSS
0.052x
Meta Financial Group Inc
NASDAQ:CASH
0.274x
KPIT Technologies Limited
NSE:KPITTECH
0.112x
Westone Information Industry Inc
SHE:002268
-0.033x
Pharvaris BV
NASDAQ:PHVS
-0.098x
SK Bioscience Co Ltd
KO:302440
0.010x
VIVENDI UNSPON.ARD EO 55
F:VVUD
N/A

Annual Cash Flow Conversion Efficiency for ZAI LAB LTD0000006 (2021–2025)

The table below shows the annual cash flow conversion efficiency of ZAI LAB LTD0000006 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see 1ZLB market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €715.50 Million
≈ $836.49 Million
€-150.79 Million
≈ $-176.29 Million
-0.211x +17.52%
2024-12-31 €840.90 Million
≈ $983.10 Million
€-214.87 Million
≈ $-251.20 Million
-0.256x -2.65%
2023-12-31 €796.12 Million
≈ $930.75 Million
€-198.18 Million
≈ $-231.69 Million
-0.249x +29.20%
2022-12-31 €1.05 Billion
≈ $1.22 Billion
€-367.64 Million
≈ $-429.81 Million
-0.352x +11.66%
2021-12-31 €1.38 Billion
≈ $1.61 Billion
€-549.23 Million
≈ $-642.11 Million
-0.398x --

About ZAI LAB LTD0000006

F:1ZLB Germany Biotechnology
Market Cap
$2.06 Billion
€1.76 Billion EUR
Market Cap Rank
#6418 Global
#963 in Germany
Share Price
€1.57
Change (1 day)
+0.00%
52-Week Range
€1.36 - €3.30
All Time High
€152.00
About

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for … Read more